Fiberoptic bronchoscopy (FB) has a low yield in the diagnosis of chronic cough (>3 weeks) in unselected pa tients. We assessed the yield of FB for cough during a fouryear period in patients with nonlocalizing chest roentgenograms who were refractory to diagnostic efforts and empiric bronchodilator or antitussive therapy. Seven (28 percent) of 25 patients undergoing FB for cough (of > 1,500 bronchoscopies) had diagnostic findings (broncholithiasis, two; tracheobronchopathia osteochondroplastica, two; and tuber culous bronchostenosis, laryngeal dyskinesia, and arytenoid polyp, one each). No tracheobronchial neoplasms were detected. Age >50 years and female sex independently predicted positive results (p = 0.02 Fisher's exact test), while duration of cough (two to 240 months), airflow, and smoking status did not. When patients with prior pulmonary or extrathoracic neoplasms were excluded, seven (35 percent) of 20 studies were diagnostic. Diagnoses potentially could have been made by thoracic computed tomographic scan ning in four patients and indirect laryngoscopy in two. Fiberoptic bronchoscopy has a respectable yield for diag nosis of refractory chronic cough and is a reasonable procedure in carefully selected patients. (Chest 1991; 99:33-35) 
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Fiberoptic bronchoscopy (FB) has a low yield in the diagnosis of chronic cough (>3 weeks) in unselected pa tients. We assessed the yield of FB for cough during a fouryear period in patients with nonlocalizing chest roentgenograms who were refractory to diagnostic efforts and empiric bronchodilator or antitussive therapy. Seven (28 percent) of 25 patients undergoing FB for cough (of > 1,500 bronchoscopies) had diagnostic findings (broncholithiasis, two; tracheobronchopathia osteochondroplastica, two; and tuber culous bronchostenosis, laryngeal dyskinesia, and arytenoid polyp, one each). No tracheobronchial neoplasms were detected. Age >50 years and female sex independently predicted positive results (p = 0.02 Fisher's exact test), while duration of cough (two to 240 months), airflow, and smoking status did not. When patients with prior pulmonary or extrathoracic neoplasms were excluded, seven (35 percent) of 20 studies were diagnostic. Diagnoses potentially could have been made by thoracic computed tomographic scan ning in four patients and indirect laryngoscopy in two. Fiberoptic bronchoscopy has a respectable yield for diag nosis of refractory chronic cough and is a reasonable procedure in carefully selected patients. (Chest 1991; 99:33-35) /Chronic persistent cough is a common annoyancê^f or patients, may portend serious underlying disease, and is a frequent source of referral to chestphysicians. ' The landmark studies of Irwin et alz and Poe et al3 demonstrated several principles, including the high diagnostic yield of the "anatomic diagnostic protocol," the frequency of asthma, postnasal drip, and their combination in the origin of cough, the limited role of fiberoptic bronchoscopy (FB) as a primary diagnostic technique, and the success of specific therapy in eliminating cough. Irwin and colleagues4'6 have reported the significance of gastroesophageal reflux in the origin of chronic cough. Although FB as the primary diagnostic modality is infrequently diagnostic in patients with chronic cough, FB may detect laryngeal abnormalities such as polyps and laryngeal dyskinesia,7 tracheal abnormalities, in cluding tracheobronchopathia osteochrondroplastica, and endobronchial foreign bodies, neoplasms (eg, bronchial adenoma), bronchostenosis, and broncholi thiasis. Rarely, patients with sarcoidosis or lymphangitic carcinoma have minimal or no roentgenographic abnormalities and diagnostic bronchoscopy. We re viewed our experience with FB at the National Naval Medical Center for chronic, unexplained cough, re fractory to empiric therapy and found diagnoses in more than a quarter of patients. 
METHODS
One of the authors (R.P.S.) reviewed records of FBs performed from 1985to 1988at the National Naval Medical Center for chronic (>3 weeks), unexplained cough. Patients with hemoptysis, the acquired immunodeficiency syndrome, or with roentgenograms suggesting the primary diagnosis (eg, interstitial lung disease, neoplasm, infection) were excluded. During this period, more than 1,500 FBs were performed and several hundred patients were referred primarily for evaluation of cough. Consultations, outpatient records, and interviews with consulting physicians established each patient's age, smoking status, cough duration, response to empiric therapy (when applicable), and final diagnosis. The group with diagnostic FB (group 1)was compared with the group with nondiagnostic FB (group 2) using Fisher's exact test.
RESULTS
The clinical findings are summarized in Tables 1  and 2 . There were 16 women and nine men, with a mean age of 54.6 years (range, 28 to 75 years). Duration of cough ranged from two to 240 months, with a mean of 48.4 months. Diagnostic findings were seen at bronchoscopy in seven (28 percent) of 25 patients, and seven (35 percent) of 20 when patients with prior pulmonary or extrathoracic neoplasms were excluded. Broncholithiasis and tracheobronchopathia osteochon- 
DISCUSSION
Bronchoscopy is a time-honored diagnostic study in the patient with unexplained cough." Its availability and relatively low morbidity have encouraged wide spread use. A recent editorial reemphasized the infrequent utility of FB for cough, the lack of specific ity of methacholine inhalation challenge, and the potential (about 25 percent of cases) for multiple etiologies for chronic cough. 9 We have been outspoken critics of the possible excessive use of diagnostic FB.10 Nevertheless, patient concern about underlying malig nancy and physician diagnostic uncertainty and con cern about delayed diagnosis will probably continue its regular use."
Armed with the pioneering work of Irwin et al2 and Poe et al, 3 we have focused FB on the small group of patients in whom history, physical examination, spirometry (with methacholine inhalation challenge as necessary), and empiric therapy (smoking cessation, withdrawal of treatment with offending drugs, bronchodilator therapy, oral or nasal corticosteroids, and antireflux therapy) fail to resolve cough. We seldom perform invasive investigations for gastroesophageal reflux, and our limited observations between esophageal pH monitoring and response to antireflux therapy have been inconsistent (unpublished data). Our ap proach excludes patients unlikely to benefit from FB, and it avoids expensive and even minimally invasive testing like esophageal pH monitoring, yet it is still successful in most patients.
We acknowledge that our results may or may not apply to other populations. The mean duration of cough (48.4 months) in our study is similar to that (39.8 and 53 months) in the two series of Irwin et al.2 '5 Although we practice in a military setting, most patients undergoing bronchoscopy for cough were women, unlike our entire bronchoscopy population, which is 70 percent male. We acknowledge that although FB enjoyed its greatest diagnostic yield in older women, this carries no "biological plausibility," based on the diagnoses established. Despite diagnoses ( Table 2) , most of these conditions were not amenable to relief by simple, reliable therapy, although all benefited from specific or intensive nonspecific antitussive therapy. Equally disappointing was the failure of smoking history, presence of airflow obstruction, or duration of cough to predict diagnostic outcome. These findings are limited by the small size of this sample.
We speculate that indirect laryngoscopy and chest computed tomography (in cough refractory to treat ment) may have a greater potential (to identify laryn geal and airway abnormalities) than previously recog nized. The cost of computed tomography as well as need for bronchoscopic confirmation in many instances would limit its utility. In a selected population, FB is not only indicated but has a significant diagnostic potential. We conclude the following: (1) in most patients referred for chronic cough, few will have laryngeal, tracheal, or endobronchial disease diag nosed by FB; (2) in patients refractory to therapy based on clinical evaluation, FB may have a significant diagnostic yield; and (3) unlike nonbronchoscopic diagnoses, diagnoses established by FB may be more difficult to treat. Results may vary among populations of patients studied.
